Aries Agro Ltd (CN)
Aries Agro Ltd (CN) operates in the agricultural chemicals industry, manufacturing and supplying agrochemical products, primarily insecticides, herbicides, and fungicides, to the Indian and international markets.
Business. Aries Agro Ltd (CN) is an Indian company operating in the agricultural chemicals industry within the broader chemicals sector. The firm is primarily listed on the National Stock Exchange of India under the ticker symbol ARAI.NS. Specific details regarding its operating segments, headquarters location, and geographic revenue mix are not available in the provided data. Consequently, the company is described at the industry level as a participant in the agricultural chemicals market.
Analyst recommendations
1 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Aries Agro Ltd (CN) is an Indian company operating in the agricultural chemicals industry within the broader chemicals sector. The firm is primarily listed on the National Stock Exchange of India under the ticker symbol ARAI.NS. Specific details regarding its operating segments, headquarters location, and geographic revenue mix are not available in the provided data. Consequently, the company is described at the industry level as a participant in the agricultural chemicals market.
Aries Agro Ltd maintains a conservative capital structure, with a debt-to-equity ratio of 0.17, indicating a low reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 1.69, suggesting it can cover its short-term obligations but with limited excess capacity. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints.
In terms of profitability, Aries Agro Ltd reports a return on equity (ROE) of 11.75% and a return on assets (ROA) of 5.85%. These figures are in line with the industry's preferred metrics, which emphasize ROE and ROA as key indicators of capital efficiency and asset utilization. The company's operating margin is 9.4%, and its net margin is 5.5%, both of which are within the typical range for the agricultural chemicals industry.
The company's revenue is primarily concentrated in India, with no disclosed international revenue segments. The lack of geographic diversification may expose the company to regional economic and regulatory risks. Additionally, the company does not report segment-specific revenue, making it difficult to assess the contribution of different product lines or markets to overall performance.
Looking ahead, the company's growth trajectory is expected to remain stable, with no significant revenue growth projected in the current or next fiscal year. The company's capital expenditure is negative, indicating a reduction in investment in physical assets, which may suggest a focus on cost optimization or a slowdown in expansion plans. The company's free cash flow is modest at INR 90.25 million, which may limit its ability to fund new initiatives or return capital to shareholders.
The company's risk profile is characterized by a low dilution potential, with no significant dilution sources identified in the available documentation. However, the negative net cash position and the absence of a detailed capital allocation strategy may pose risks to long-term financial stability. The company's liquidity risk is moderate, as it maintains a current ratio above 1.5 but has limited cash reserves relative to its debt obligations.
Recent filings and transcripts do not indicate any material events or strategic shifts. The company's latest financial report highlights stable operations and a focus on maintaining profitability amid fluctuating raw material costs. No significant regulatory or legal issues have been disclosed in the available documentation.
- Aries Agro Ltd maintains a conservative capital structure with a low debt-to-equity ratio of 0.17.
- The company's return on equity (11.75%) and return on assets (5.85%) are in line with industry norms.
- Revenue is concentrated in India, with no disclosed international operations, increasing regional exposure.
- Free cash flow is modest at INR 90.25 million, limiting the company's ability to fund new initiatives.
- The company's liquidity position is medium, with a current ratio of 1.69 and a negative net cash position after debt.
- No significant dilution sources or regulatory risks have been identified in the available documentation.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- Director, Chief Strategy Officer · Restricted Stock Award → Common StockAcquired 25 348exercise · 2026-03-31
- Director · Restricted Stock Award → Common StockAcquired 47 052grant · 2026-03-31
- Chief Financial Officer · Restricted Stock Award → Common StockAcquired 35 488exercise · 2026-03-31
- Director, Chief Strategy Officer · Restricted Stock Award → Common StockAcquired 566 038grant · 2026-03-31
- Chief Financial Officer · Restricted Stock Award → Common StockAcquired 792 452grant · 2026-03-31
- Director · Restricted Stock Award → Common StockAcquired 47 052grant · 2026-03-31
- Director · Restricted Stock Award → Common StockAcquired 47 052grant · 2026-03-31
- Director, Chief Operating Officer · Restricted Stock Award → Common StockAcquired 41 656exercise · 2026-03-31
- Director, Chief Operating Officer · Restricted Stock Award → Common StockAcquired 930 188grant · 2026-03-31
- Director, Chief Strategy Officer · Restricted Stock Award → Common StockAcquired 76 046grant · 2025-12-31
- Director · Restricted Stock Award → Common StockAcquired 14 259grant · 2025-12-31
- Director, Chief Operating Officer · Restricted Stock Award → Common StockAcquired 124 969grant · 2025-12-31
- Director · Restricted Stock Award → Common StockAcquired 14 259grant · 2025-12-31
- Director · Restricted Stock Award → Common StockAcquired 14 259grant · 2025-12-31
- Chief Financial Officer · Restricted Stock Award → Common StockAcquired 106 464grant · 2025-12-31
- VP Business Development · Restricted Stock Award → Common StockAcquired 12 082grant · 2025-12-19
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Aries Agro Ltd (CN) Market data — financials · 2026-05-27
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2025-12-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
Insider activity
- Director, Chief Operating Officer · Common StockOther 12 352 · 2026-03-31
- Chief Financial Officer · Common StockOther 11 641 · 2026-03-31
- Chief Financial Officer · Common StockOther 35 488 · 2026-03-31
- Director, Chief Strategy Officer · Common StockOther 25 348 · 2026-03-31
- Director, Chief Strategy Officer · Common StockOther 8 315 · 2026-03-31
- Director, Chief Operating Officer · Common StockOther 41 656 · 2026-03-31
- Director, Chief Strategy Officer · Common StockBought 1 390 @ $3,53$5K · 2025-11-19
- Director, Chief Executive Officer, 10% owner · Common StockBought 11 142 @ $3,50$39K · 2025-11-18
- Director · Common StockOther 7 292 · 2025-10-06
- Director · Common StockOther 7 292 · 2025-10-06
- Director · Common StockOther 7 292 · 2025-10-06
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Total assets (YoY) (2025-12-31 vs 2024-12-31): 1,006.6%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -260.5%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 351.8%Derived (calculated)
- Net margin (FY 2025-12-31): -11,325.7%Derived (calculated)
- Return on assets (FY 2025-12-31): -117.3%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): -182.7%Derived (calculated)
- Capex (YoY) (2025-12-31 vs 2024-12-31): 1,197.8%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): -21.0%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): -150.0%Derived (calculated)
- Current ratio (FY 2025-12-31): 0.34xDerived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 329.0%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): -150.0%Derived (calculated)
- Debt-to-equity (FY 2025-12-31): 3.42xDerived (calculated)
- Return on equity (FY 2025-12-31): -518.1%Derived (calculated)
- Capex (annual): USD 495.19KSEC XBRL filing
- Net income (annual): USD -12.83MSEC XBRL filing
- Shareholders' equity (annual): USD 2.48MSEC XBRL filing
- R&D expense (annual): USD 600.51KSEC XBRL filing
- Total assets (annual): USD 10.93MSEC XBRL filing
- Operating cash flow (annual): USD -8.25MSEC XBRL filing
- Shares outstanding (annual): 34.21MSEC XBRL filing
- Current liabilities (annual): USD 6.73MSEC XBRL filing
- Current assets (annual): USD 2.31MSEC XBRL filing
- Total liabilities (annual): USD 8.46MSEC XBRL filing